Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tina-quant C-Reactive Protein IV

K-Number: K192072 · 2020-02-21

Decision Date2020-02-21
Product CodeDCN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Tina-quant C-Reactive Protein IV is the device name listed in this FDA 510(k) record. The listed applicant is Roche Diagnostics Operations (Rdo). It received FDA 510(k) clearance on 2020-02-21 under 510(k) number K192072. The device is classified under product code DCN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tina-quant C-Reactive Protein IV?

Tina-quant C-Reactive Protein IV is a medical device that received FDA 510(k) clearance on 2020-02-21. The listed applicant is Roche Diagnostics Operations (Rdo). The 510(k) number is K192072.

When did Tina-quant C-Reactive Protein IV receive FDA 510(k) clearance?

Tina-quant C-Reactive Protein IV received FDA 510(k) clearance on 2020-02-21, under 510(k) number K192072.

Who is the listed applicant for Tina-quant C-Reactive Protein IV?

The FDA 510(k) record lists Roche Diagnostics Operations (Rdo) as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Tina-quant C-Reactive Protein IV?

The FDA product code for Tina-quant C-Reactive Protein IV is DCN.

Other records listing Roche Diagnostics Operations (Rdo) as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 10 devices →

Related Devices (Code: DCN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.